NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,020,000 | -57.0% | 82,325 | -6.4% | 0.02% | -58.5% |
| Q1 2018 | $9,345,000 | +300.6% | 87,943 | +125.1% | 0.05% | +307.7% |
| Q4 2017 | $2,333,000 | +688.2% | 39,070 | +216.6% | 0.01% | +550.0% |
| Q3 2017 | $296,000 | +55.0% | 12,340 | +10.9% | 0.00% | 0.0% |
| Q3 2016 | $191,000 | -10.7% | 11,125 | -26.1% | 0.00% | 0.0% |
| Q2 2016 | $214,000 | -15.1% | 15,045 | -27.8% | 0.00% | -33.3% |
| Q1 2014 | $252,000 | +104.9% | 20,824 | +91.9% | 0.00% | +200.0% |
| Q4 2013 | $123,000 | -72.7% | 10,854 | -74.9% | 0.00% | -83.3% |
| Q3 2013 | $451,000 | -11.2% | 43,224 | -1.7% | 0.01% | -14.3% |
| Q2 2013 | $508,000 | – | 43,974 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |